MYOMICS, INC.

Basic Information

MYOMICS, INC.
148 West River Street
PROVIDENCE, RI, 02904 2615

Company Profile

n/a

Additional Details

Field Value
DUNS: 139717537
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. High Content Screening for Muscular Dystrophy

    Amount: $991,988.00

    DESCRIPTION (provided by applicant): Duchenne Muscular Dystrophic (DMD) is a fatal genetic disease affecting tens of thousands of boys in the U.S. There is currently no cure for the disease and few d ...

    SBIR Phase II 2009 Department of Health and Human Services
  2. High Content Drug Screening with Cardiac Tissue

    Amount: $98,136.00

    DESCRIPTION (provided by applicant): Myomics, Inc. has developed High Content Drug Screening (HCS) technology for in vitro testing of compounds which alter contractile forces generated by miniaturized ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. SBIR Phase II: Physiologic High Throughput Screening of Bioengineered Tissues

    Amount: $499,956.00

    This Small Business Innovation Research (SBIR) Phase II research develops an innovative high-throughput/high content drug screening platform that utilizes three-dimensional human skeletal muscle tissu ...

    SBIR Phase II 2007 National Science Foundation
  4. High Content Screening for Muscular Dystrophy

    Amount: $99,912.00

    DESCRIPTION (provided by applicant): Myomics' drug screening technology to be developed in this Phase 1 SBIR project for Duchene muscular dystrophy (DMD) is based upon an in vitro skeletal muscle tiss ...

    SBIR Phase I 2007 Department of Health and Human Services
  5. Electro-Mechanical Micro-Post Array to Detect In Vitro Muscle Contraction

    Amount: $99,939.00

    DESCRIPTION (provided by applicant): Myomics? technology to be developed in this Phase 1 project is based upon an in vitro skeletal muscle tissue force measurement technique for high throughput screen ...

    STTR Phase I 2006 Department of Health and Human Services
  6. SBIR Phase I: Physiologic High Throughput Screening of Bioengineered Tissues

    Amount: $99,991.00

    The Small Business Innovation Research (SBIR) Phase I project will develop an innovative high-throughput/ high content drug screening platform utilizing three-dimensional human skeletal muscle tissue ...

    SBIR Phase I 2006 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government